Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the efficacy of different dosing and scheduling of
Nolvadex in preventing gynecomastia/mastalgia induced by Casodex 150 mg monotherapy in
patients with prostate cancer.